Celularity Inc. (NASDAQ: CELU)
$2.1050
+0.6550 ( +45.17% ) 8.3M
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.
Market Data
Open
$2.1050
Previous close
$1.4500
Volume
8.3M
Market cap
$46.17M
Day range
$1.5050 - $2.6350
52 week range
$1.3000 - $7.9700
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 14 | Aug 23, 2024 |
nt | Quarterly Reports | 1 | Aug 16, 2024 |
8-k | 8K-related | 15 | Aug 05, 2024 |
10-k | Annual reports | 119 | Jul 30, 2024 |
8-k | 8K-related | 14 | May 24, 2024 |
8-k | 8K-related | 74 | May 21, 2024 |
nt | Quarterly Reports | 1 | May 15, 2024 |
8-k | 8K-related | 14 | Apr 22, 2024 |
4 | Insider transactions | 1 | Apr 16, 2024 |
4 | Insider transactions | 1 | Apr 16, 2024 |